https://mbcbiolabs.com/wp-content/uploads/2024/10/jupiter-bioventures.svgThe good, the bad, and the totally bad: lessons from 25 years building biotech companiesNed is a biochemist and drug hunter who co-founded Jupiter, a biotech foundry that turns early science into new biotech companies. Ned will review his 25 years of biotech company building: what went right (i.e., approved medicines with great investor returns) and what went spectacularly, phantasmagorically wrong (e.g., imagine smoldering craters of vaporized venture capital). Ned will also discuss the Jupiter model of company creation as one way to tackle audacious biotech projects while thoughtfully managing risk.Our Speakerhttps://mbcbiolabs.com/wp-content/uploads/2024/10/NedDavid-Jupiter.jpgNathaniel "Ned" David, PhDBefore co-founding Jupiter, Ned co-founded four companies, three of which went public on NASDAQ while one was acquired: Kythera Biopharmaceuticals (NASDAQ: KYTH, later acquired by Allergan), Achaogen (NASDAQ: AKAO), UNITY Biotechnology (NASDAQ: UBX), and Syrrx (acquired by Takeda), companies that together created four approved medicines (ALOGLIPTIN, TRELAGLIPTIN, ZEMDRI, and KYBELLA). Ned earned his PhD in Molecular and Cellular Biology from UC Berkeley, his AB in Biology from Harvard College, and is an inventor on 70 allowed patents. He likes baking and Bach. Register

https://mbcbiolabs.com/wp-content/uploads/2024/10/Switch-logo-300x141.pngThe 10 hottest years have all been in the last 10 years. Part of the problem is fertilizer -- essential in feeding the planet, but emitting over a gigaton of CO2 equivalent emissions every year. Switch Bioworks engineers symbiotic microbes to produce sustainable and cost-effective nitrogen fertilizer under the control of precise genetic circuits. Join us for an overview of Switch Bioworks and a fireside chat with their founder Tim Schnabel, and researchers Carol Kukolj and Kristi Yanagihara. Our Speakers https://mbcbiolabs.com/wp-content/uploads/2024/10/Tim-Schnabel-225x300.jpgTim Schnabel Founder, CEO, and Board MembersDr. Tim Schnabel is a scientist, bioengineer, entrepreneur, and Forbes 30 under 30 honoree in social impact. He is currently serving as the Founder and CEO of Switch Bioworks, a biotechnology company located in San Carlos, California, focused on engineering microbes that produce cost-effective, sustainable fertilizer to tackle climate change. Originally from Germany, Tim came to the US to study chemical engineering and economics at Stanford University (’15). Under the guidance of Professor James Swartz, he researched the biological production of hydrogen fuel from sunlight and received Stanford's Kennedy Thesis Prize, the highest university recognition for undergraduate research. Tim’s research also won the Mason Award and Firestone Medal, and his academic recognition include the [...]